You’ve got hate in your heart mate. But it’s a fair point. Plus the price is only back up to where it was the other week. Just as likely to drop back down again tomorrow
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%